Who's leading the CDC now?

Temporary leadership amid agency turmoil

The Centers for Disease Control and Prevention is operating under interim leadership after a recent shake-up at the agency. The director of the National Institutes of Health has stepped in to run the CDC on an acting basis while federal officials search for a permanent leader. The move follows a string of departures in senior ranks, including an abrupt resignation by the agency’s then-deputy director.

The leadership change has coincided with visible disruptions to routine advisory processes. A scheduled meeting of the agency’s vaccine advisory panel was postponed, and at least one public meeting of the advisory committee was cancelled. Those delays have immediate consequences for how and when vaccine recommendations and related guidance are reviewed and communicated to clinicians and the public.

What this means in practice:

• Advisory timelines: Delays in meetings can slow updates to vaccine schedules and public-health recommendations.
• Staff morale and continuity: Multiple senior departures risk disrupting programs that rely on institutional expertise.
• Public confidence: Rapid leadership changes and postponed advisory meetings can create confusion for clinicians and patients during outbreaks and immunization campaigns.

Officials say the interim leadership is intended as a short-term measure to keep the agency functioning. It remains unclear how long the arrangement will last and whether it will affect major policy decisions now under consideration.